Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0787 per EA under NDC 68001061305. Its NADAC has been published 111 times since Jul 10, 2024.
FDA first approved this application on Feb 2, 2022. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001061305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215568FDA Approved
2/2/2022
TE Code
AB3
On Market Since
4/8/2024
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 111 times since Jul 10, 2024, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per EA |
|---|---|
| All-time high | $0.1131 (Jul 10, 2024) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1015 |
| 52-week low | $0.0770 |
| Median price | $0.0964 |
| Average price | $0.0934 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 111 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by BluePoint Laboratories, is $0.0787 per EA (NDC 68001061305), effective Aug 19, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 30.4%. It has been tracked across 111 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Jul 10, 2024, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1131 (Jul 10, 2024), with a median of $0.0964 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0786 per EA — about 0% below BUPROPION HCL XL 150 MG TABLET.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 68001061305) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.